action of glp 1 agonist GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Frontiers | GLP−1 receptor agonists

Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent

Here's what researchers found.

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health Organization guidelines.

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Learn practical strategies to relieve discomfort during treatment.